Literature DB >> 30232188

Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.

James Hopkins1,2, Tejabhiram Yadavalli1, Alex M Agelidis1,2, Deepak Shukla3,2.   

Abstract

Herpes simplex virus 2 (HSV-2) can productively infect many different cell types of human and nonhuman origin. Here we demonstrate interconnected roles for two host enzymes, heparanase (HPSE) and cathepsin L, in HSV-2 release from cells. In vaginal epithelial cells, HSV-2 causes heparan sulfate shedding and upregulation in HPSE levels during the productive phase of infection. We also noted increased levels of cathepsin L and show that regulation of HPSE by cathepsin L via cleavage of HPSE proenzyme is important for infection. Furthermore, inhibition of HPSE by a specific inhibitor, OGT 2115, dramatically reduces HSV-2 release from vaginal epithelial cells. Likewise, we show evidence that the inhibition of cathepsin L is detrimental to the infection. The HPSE increase after infection is mediated by an increased NF-κB nuclear localization and a resultant activation of HPSE transcription. Together these mechanisms contribute to the removal of heparan sulfate from the cell surface and thus facilitate virus release from cells.IMPORTANCE Genital infections by HSV-2 represent one of the most common sexually transmitted viral infections. The virus causes painful lesions and sores around the genitals or rectum. Intermittent release of the virus from infected tissues during sexual activities is the most common cause of transmission. At the molecular level, cell surface heparan sulfate (HS) is known to provide attachment sites for HSV-2. While the removal of HS during HSV-1 release has been shown, not much is known about the host factors and their regulators that contribute to HSV-2 release from natural target cell types. Here we suggest a role for the host enzyme heparanase in HSV-2 release. Our work reveals that in addition to the regulation of transcription by NF-κB, HPSE is also regulated posttranslationally by cathepsin L and that inhibition of heparanase activity directly affects HSV-2 release. We provide unique insights into the host mechanisms controlling HSV-2 egress and spread.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HSV-2; heparanase; viral egress

Mesh:

Substances:

Year:  2018        PMID: 30232188      PMCID: PMC6232460          DOI: 10.1128/JVI.01179-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Sialic acid species as a determinant of the host range of influenza A viruses.

Authors:  Y Suzuki; T Ito; T Suzuki; R E Holland; T M Chambers; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Cell entry mechanisms of HSV: what we have learned in recent years.

Authors:  Alex M Agelidis; Deepak Shukla
Journal:  Future Virol       Date:  2015-10-01       Impact factor: 1.831

3.  Amino acid substitutions in the V domain of nectin-1 (HveC) that impair entry activity for herpes simplex virus types 1 and 2 but not for Pseudorabies virus or bovine herpesvirus 1.

Authors:  Wanda M Martinez; Patricia G Spear
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.

Authors:  Orit Goldshmidt; Eyal Zcharia; Rinat Abramovitch; Shula Metzger; Helena Aingorn; Yael Friedmann; Volker Schirrmacher; Eduardo Mitrani; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

5.  Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption.

Authors:  T Yasuma; S Oi; N Choh; T Nomura; N Furuyama; A Nishimura; Y Fujisawa; T Sohda
Journal:  J Med Chem       Date:  1998-10-22       Impact factor: 7.446

6.  The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity.

Authors:  L G Baum; J C Paulson
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

Review 7.  Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.

Authors:  Israel Vlodavsky; Neta Ilan; Annamaria Naggi; Benito Casu
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 8.  Genital herpes: natural history and treatment of acute episodes.

Authors:  G R Kinghorn
Journal:  J Med Virol       Date:  1993       Impact factor: 2.327

9.  DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer.

Authors:  Fei Jiao; Shi-Yu Bai; Ying Ma; Zhong-Hai Yan; Zhen Yue; Yuan Yu; Xin Wang; Juan Wang
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

10.  Structural characterization of human heparanase reveals insights into substrate recognition.

Authors:  Liang Wu; Cristina M Viola; Andrzej M Brzozowski; Gideon J Davies
Journal:  Nat Struct Mol Biol       Date:  2015-11-16       Impact factor: 15.369

View more
  20 in total

1.  In Vitro and In Vivo Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital Infection.

Authors:  James Hopkins; Tejabhiram Yadavalli; Rahul Suryawanshi; Farreh Qatanani; Ipsita Volety; Ram Koganti; Aqsa Iqbal; Deepak Shukla
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus 2 Release from Cells.

Authors:  James Hopkins; Tejabhiram Yadavalli; Alex M Agelidis; Deepak Shukla
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 3.  Incidence and Risk Factors of Bilateral Herpetic Keratitis: 2022 Update.

Authors:  Stergios K Chaloulis; Georgios Mousteris; Konstantinos T Tsaousis
Journal:  Trop Med Infect Dis       Date:  2022-06-07

4.  CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells.

Authors:  Tejabhiram Yadavalli; Pankaj Sharma; David Wu; Divya Kapoor; Deepak Shukla
Journal:  Viruses       Date:  2022-05-28       Impact factor: 5.818

5.  BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines.

Authors:  Aqsa Iqbal; Rahul Suryawanshi; Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Antiviral Res       Date:  2020-05-05       Impact factor: 5.970

6.  Antimicrobial, Antioxidant, and Cytotoxic Activities of Juglans regia L. Pellicle Extract.

Authors:  Floriana D'Angeli; Giuseppe Antonio Malfa; Adriana Garozzo; Giovanni Li Volti; Carlo Genovese; Aldo Stivala; Daria Nicolosi; Francesco Attanasio; Francesco Bellia; Simone Ronsisvalle; Rosaria Acquaviva
Journal:  Antibiotics (Basel)       Date:  2021-02-04

7.  An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine.

Authors:  Alex Agelidis; Lulia Koujah; Rahul Suryawanshi; Tejabhiram Yadavalli; Yogendra Kumar Mishra; Rainer Adelung; Deepak Shukla
Journal:  Front Immunol       Date:  2019-03-20       Impact factor: 7.561

Review 8.  Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?

Authors:  Valeria Cagno; Eirini D Tseligka; Samuel T Jones; Caroline Tapparel
Journal:  Viruses       Date:  2019-07-01       Impact factor: 5.048

9.  Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2.

Authors:  Qianni Duan; Tong Liu; Ping Yuan; Cong Huang; Qingqing Shao; Lijun Xu; Jun Sun; Guangyin Huang; Zhuo Chen
Journal:  J Ethnopharmacol       Date:  2019-11-16       Impact factor: 4.360

Review 10.  Heparanase, cell signaling, and viral infections.

Authors:  Raghuram Koganti; Rahul Suryawanshi; Deepak Shukla
Journal:  Cell Mol Life Sci       Date:  2020-05-27       Impact factor: 9.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.